IDO1 has been extensively studied in the context of cancer, where its overexpression is often linked to immune evasion by tumor cells, potentially through mechanisms such as inhibiting T cell activation, promoting T cell apoptosis, and expanding regulatory T cell (Treg) populations [41]. The gene discussed is IDO1; the disease is cancer.